Searched for
CIPLA Q1
Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...- Q4 earnings review: Motilal Oswal highlights broad-based beat on estimates, lists 6 sectors that exceeded expectationsMotilal Oswal said Q4 FY26 earnings surpassed expectations, with aggregate profits rising 16% year-on-year against its 8% estimate. Strong ...
- Bonus issues, dividends and more: Reliance Industries, Trent among 20 stocks turning ex-date this weekReliance Industries, Trent, and 18 other stocks are set to turn ex-date this week for corporate actions including dividends and bonus issue...
- Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- NLC India shares rally 18% to fresh record high after Q4 net profit skyrockets 189% YoYNLC India shares rose to a record high on Thursday after the company posted a 189% YoY surge in Q4 net profit to Rs 1,394 crore. Revenue ro...
- Cipla shares rally 8% despite 55% YoY slump in Q4 profit. Why Citi, Nuvama, other brokerages hiked targetCipla shares surged on Thursday, extending gains to nearly 11% in two sessions, after several brokerages turned bullish on the stock despit...
- TVS Motor Q4 Results: Cons PAT grows 19% YoY to Rs 772 crore as revenue jumps 30%TVS Motor Q4 Results: TVS Motor posted a strong Q4FY26 with net profit up 19% to Rs 772 crore and revenue rising 30% to Rs 15,053 crore. Ov...
- Cipla Q4 Results: Profit falls 55% YoY to Rs 555 crore; co declares Rs 13/sh dividendCipla Ltd announced a significant 55% year-on-year drop in its consolidated net profit for the fourth quarter, reaching Rs 555 crore. This ...
- Stocks in news: Airtel, Tata Motors, Dr Reddy's, NTPC, Dixon TechnologiesMarkets faced selling pressure on Tuesday due to weak global cues and macroeconomic concerns, with the Nifty approaching support at 23,150....
- Q4 earnings, crude oil, FII action among 8 factors to steer D-Street this weekIndian stock markets are set for a busy week. Key events like Q4 earnings announcements for many companies will influence trading. Foreign ...
- Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...
- Cipla Q1 Results: Cons PAT rises 10% YoY to Rs 1,298 crore, revenue up 4%Cipla Q1 Results: Cipla reported a 10% YoY increase in consolidated net profit, reaching Rs 1,298 crore for the June quarter, driven by a 4...
- Cipla Q1 Results: Cons PAT rises 18% YoY to Rs 1,178 crore, beats estimatesCipla Q1 Results: The profit beat the ET Now Poll estimates of Rs 1,071 crore. Revenue from operations in the reporting period increased 6%...
- Cipla Q1 Results: Net profit jumps 45% YoY, to end FY24 with 23.5% EBITDA marginsCipla expects to finish FY24 with 23-23.5% EBITDA margins and more than 10% revenue growth. Robust sales growth in the US, India, and South...
- Cipla Q1 Results: Cons PAT soars 45% YoY to Rs 996 crore, beats estimatesConsolidated operating profit, calculated as earnings before interest, taxes, depreciation, and amortization (EBITDA), grew by 31% on year ...
- Cipla Q1 Results: Profit falls 4% YoY to Rs 686 crore but beats estimatesHowever, the profit figure managed to beat Rs 601 crore figure anticipated by analysts in an ET NOW poll. An ET NOW poll had anticipated th...
- Cipla Q1 results: Consolidated PAT rises 24% YoY, beats estimate; sales jump 27%The pharmaceutical major reported a 27 per cent rise in income from operations to Rs. 5,504 crore for the quarter ended June, which was als...
Load More
